Genentech

News

Roche inks pipeline deals with Orionis, PeptiDream

Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87

News

Genentech withdraws US indication of Tecentriq for bladder, ...

Genentech, a

News

Illustration of a nerve cell on a colored background with light effects

Alzheimer's treatment hopes take another dive as Roche drug ...

Roche's Genentech division has reported disappointing top-line results from its highly-anticipated phase 3 trial of gantenerumab in early Alzheimer's disease, in yet another setback for an

News

Roche puts $70m into ArsenalBio's programmable T-cell platfo...

Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform.

News

Roche adds to pipeline with Poseida, Kiniksa deals

Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases.

News

Roche rings Bicycle bell again, grabbing another cancer targ...

Roche's Genentech unit has gone all in on its collaboration with UK biotech Bicycle Therapeutics, taking up an option on a second additional target in the area of cancer immunotherapy.

Roche inks pipeline deals with Orionis, PeptiDream

Genentech withdraws US indication of Tecentriq for bladder, ...

Alzheimer's treatment hopes take another dive as Roche drug ...

Roche puts $70m into ArsenalBio's programmable T-cell platfo...

Roche adds to pipeline with Poseida, Kiniksa deals

Roche rings Bicycle bell again, grabbing another cancer targ...

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Genentech

Editor's Picks